Hartmut Bertz

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 17

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Bone marrow transplantation

Integrative cancer therapies

This page only lists publications with an associated author ORCID identifier.

Publications

Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Miguel Waterhouse, Sandra Pennisi, Dietmar Pfeifer, Florian Scherer, Robert Zeiser, Justus Duyster, Hartmut Bertz, Juergen Finke, Jesus Duque-Afonso
Monitoring of Measurable Residual Disease Using Circulating DNA after Allogeneic Hematopoietic Cell Transplantation. Cancers 14 (14) (2022)
Thomas Meyer, Gabriele Ihorst, Ingrid Bartsch, Robert Zeiser, Ralph Wäsch, Hartmut Bertz, Juergen Finke, Daniela Huzly, Claudia Wehr
Cellular and Humoral SARS-CoV-2 Vaccination Responses in 192 Adult Recipients of Allogeneic Hematopoietic Cell Transplantation. Vaccines 10 (11) (2022)
Sarah Kneis, Elisa Straub, Isabelle Daniela Walz, Philipp von Olshausen, Anja Wehrle, Albert Gollhofer, Hartmut Bertz
Gait Analysis of Patients After Allogeneic Hematopoietic Cell Transplantation Reveals Impairments of Functional Performance. Integrative cancer therapies 19 (2021)
Stefanie Zorn, Janine Ehret, Rebecca Schäuble, Beate Rautenberg, Gabriele Ihorst, Hartmut Bertz, Paul Urbain, Anna Raynor
Impact of modified short-term fasting and its combination with a fasting supportive diet during chemotherapy on the incidence and severity of chemotherapy-induced toxicities in cancer patients - a controlled cross-over pilot study. BMC cancer 20 (1) (2020)
Jannik Stemler, Jon Salmanton-García, Danila Seidel, Barbara Dudley Alexander, Hartmut Bertz, Martin Hoenigl, Raoul Herbrecht, Lisa Meintker, Arne Meißner, Sibylle C Mellinghoff, Ertan Sal, Marouan Zarrouk, Philipp Köhler, Oliver Andreas Cornely
Risk factors and mortality in invasive Rasamsonia spp. infection: Analysis of cases in the FungiScope® registry and from the literature. Mycoses 63 (3) (2019)
Sarah Kneis, Anja Wehrle, Anne Ilaender, Natalja Volegova-Neher, Albert Gollhofer, Hartmut Bertz
Results From a Pilot Study of Handheld Vibration: Exercise Intervention Reduces Upper-Limb Dysfunction and Fatigue in Breast Cancer Patients Undergoing Radiotherapy: VibBRa Study. Integrative cancer therapies 17 (3) (2018)